Drug intelligence / Profile preview

AniVox Ear Wash

Development stage: Unknown
Lead developer: Repolar Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

AniVox Ear Wash is a topical veterinary ear cleaning product developed by Repolar Pharmaceuticals Oy. It is formulated using Norway Spruce (*Picea abies*) resin extracted via the patented Resol Technology, combined with allantoin for soothing effects. The product is designed for the treatment and prevention of acute and chronic ear conditions in animals, particularly dogs and cats. It functions by dissolving earwax and cleansing irritated, itchy, or secreting ear canals. The resin components provide antimicrobial activity against common pathogens such as *Staphylococcus* bacteria and *Malassezia* yeasts. It is a natural, alcohol-free, and perfume-free solution that is safe for use even in cases of a perforated eardrum.

Brand names: AniVox Ear WashAniVox
Other names: AniVox® Ear Wash

Beyond the preview

Go deeper on AniVox Ear Wash.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AniVox Ear Wash.

Explore the full profile